This review highlights the recent and prolific progress made in the use of iron–phosphine based catalysts in selective reductions including enantioselective hydrogenation.
No takes yet. Share an insight, caveat, or question.
Castro et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: